Cargando…
BMX controls 3βHSD1 and sex steroid biosynthesis in cancer
Prostate cancer is highly dependent on androgens and the androgen receptor (AR). Hormonal therapies inhibit gonadal testosterone production, block extragonadal androgen biosynthesis, or directly antagonize AR. Resistance to medical castration occurs as castration-resistant prostate cancer (CRPC) and...
Autores principales: | Li, Xiuxiu, Berk, Michael, Goins, Christopher, Alyamani, Mohammad, Chung, Yoon-Mi, Wang, Chenyao, Patel, Monaben, Rathi, Nityam, Zhu, Ziqi, Willard, Belinda, Stauffer, Shaun, Klein, Eric, Sharifi, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843047/ https://www.ncbi.nlm.nih.gov/pubmed/36647826 http://dx.doi.org/10.1172/JCI163498 |
Ejemplares similares
-
Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation
por: Cui, Di, et al.
Publicado: (2023) -
Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer
por: Ko, Hyun-Kyung, et al.
Publicado: (2018) -
BMX: Biological modelling and interface exchange
por: Palmer, Bruce J., et al.
Publicado: (2023) -
Rapid and structure-specific cellular uptake of selected steroids
por: McManus, Jeffrey M., et al.
Publicado: (2019) -
Current understanding of tyrosine kinase BMX in inflammation and its inhibitors
por: Qiu, Le, et al.
Publicado: (2014)